Search research articles
Contact Us
Filters
Showing results (31-40 of 72) with videos related to
Page
of 8
Sort By:
Haematologica
|
March 8, 2005
The impact of the combination of baseline risk group and cytogenetic response on the survival of patients with chronic myeloid leukemia treated with interferon alpha
Joerg Hasford, Markus Pfirrmann, Pat Shepherd, et al.
Wiener Klinische Wochenschrift
|
March 29, 2013
Experience with lenalidomide in an Austrian non-study population with advanced myelofibrosis
Sonja Burgstaller, Michael Fridrik, Sabine Hojas, et al.
Cancer
|
February 10, 2010
Reduced incidence of infusion-related reactions in metastatic colorectal cancer during treatment with cetuximab plus irinotecan with combined corticosteroid and antihistamine premedication
Salvatore Siena, Robert Glynne-Jones, Antoine Adenis, et al.
Leukemia Research
|
August 4, 2004
Elevated levels of soluble CD44 are associated with advanced disease and in vitro proliferation of neoplastic lymphocytes in B-cell chronic lymphocytic leukaemia
Wolfgang Eisterer, Oliver Bechter, Ola Söderberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 16, 2008
Cetuximab plus irinotecan in heavily pretreated metastatic colorectal cancer progressing on irinotecan: MABEL Study
Hansjochen Wilke, Robert Glynne-Jones, Josef Thaler, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
April 2, 2009
Are gender-associated differences in quality of life in colorectal cancer patients disease-specific?
Johannes Giesinger, Georg Kemmler, Verena Mueller, et al.
Anticancer Research
|
December 27, 2011
Oxaliplatin, irinotecan and cetuximab in advanced gastric cancer. A multicenter phase II trial (Gastric-2) of the Arbeitsgemeinschaft Medikamentose Tumortherapie (AGMT)
Ewald Wöll, Richard Greil, Wolfgang Eisterer, et al.
Anticancer Research
|
October 7, 2017
Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients - AGMT_GASTRIC-3
Ewald Wöll, Josef Thaler, Felix Keil, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
November 24, 2017
A prospective, multicenter pilot study to investigate the feasibility and safety of a 1-year controlled exercise training after adjuvant chemotherapy in colorectal cancer patients
Gudrun Piringer, Michael Fridrik, Alfred Fridrik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 9, 2010
Light chain-induced acute renal failure can be reversed by bortezomib-doxorubicin-dexamethasone in multiple myeloma: results of a phase II study
Heinz Ludwig, Zdenek Adam, Roman Hajek, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 72) with videos related to
Sort By:
Page
of 8
Haematologica
|
March 8, 2005
The impact of the combination of baseline risk group and cytogenetic response on the survival of patients with chronic myeloid leukemia treated with interferon alpha
Joerg Hasford, Markus Pfirrmann, Pat Shepherd, et al.
Wiener Klinische Wochenschrift
|
March 29, 2013
Experience with lenalidomide in an Austrian non-study population with advanced myelofibrosis
Sonja Burgstaller, Michael Fridrik, Sabine Hojas, et al.
Cancer
|
February 10, 2010
Reduced incidence of infusion-related reactions in metastatic colorectal cancer during treatment with cetuximab plus irinotecan with combined corticosteroid and antihistamine premedication
Salvatore Siena, Robert Glynne-Jones, Antoine Adenis, et al.
Leukemia Research
|
August 4, 2004
Elevated levels of soluble CD44 are associated with advanced disease and in vitro proliferation of neoplastic lymphocytes in B-cell chronic lymphocytic leukaemia
Wolfgang Eisterer, Oliver Bechter, Ola Söderberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 16, 2008
Cetuximab plus irinotecan in heavily pretreated metastatic colorectal cancer progressing on irinotecan: MABEL Study
Hansjochen Wilke, Robert Glynne-Jones, Josef Thaler, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
April 2, 2009
Are gender-associated differences in quality of life in colorectal cancer patients disease-specific?
Johannes Giesinger, Georg Kemmler, Verena Mueller, et al.
Anticancer Research
|
December 27, 2011
Oxaliplatin, irinotecan and cetuximab in advanced gastric cancer. A multicenter phase II trial (Gastric-2) of the Arbeitsgemeinschaft Medikamentose Tumortherapie (AGMT)
Ewald Wöll, Richard Greil, Wolfgang Eisterer, et al.
Anticancer Research
|
October 7, 2017
Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients - AGMT_GASTRIC-3
Ewald Wöll, Josef Thaler, Felix Keil, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
November 24, 2017
A prospective, multicenter pilot study to investigate the feasibility and safety of a 1-year controlled exercise training after adjuvant chemotherapy in colorectal cancer patients
Gudrun Piringer, Michael Fridrik, Alfred Fridrik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 9, 2010
Light chain-induced acute renal failure can be reversed by bortezomib-doxorubicin-dexamethasone in multiple myeloma: results of a phase II study
Heinz Ludwig, Zdenek Adam, Roman Hajek, et al.
Page
of 8